Membrane layers for analyte sensors

US11262326B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11262326-B2
Application numberUS-201615395892-A
CountryUS
Kind codeB2
Filing dateDec 30, 2016
Priority dateDec 30, 2015
Publication dateMar 1, 2022
Grant dateMar 1, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer can comprises a biointerface polymer, wherein the biointerface polymer comprises polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise an enzyme layer, wherein the enzyme layer comprises an enzyme and a polymer comprising polyurethane and/or polyurea segments and one or more zwitterionic repeating units. The sensing membrane can also comprise a diffusion-resistance layer, which can comprise a base polymer having a lowest Tg of greater than −50 C.

First claim

Opening claim text (preview).

What is claimed is: 1. A device for monitoring an analyte concentration, the device comprising: a transcutaneous sensor configured to generate a signal associated with a concentration of an analyte; an enzyme layer; and a membrane located over both the transcutaneous sensor and the enzyme layer; wherein the membrane comprises a diffusion-resistance layer comprising a base polymer, the base polymer comprising silicone, wherein the silicone comprises less than 1 wt % of the base polymer, and the base polymer has a lowest glass transition temperature as measured using ASTM D3418 of greater than −50° C., and the base polymer has an ultimate tensile strength as measured by ASTM D1708 that is greater than 6000 psi. 2. The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is greater than 0° C. 3. The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 0° C. to 66° C. 4. The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 20° C. to 60° C. 5. The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 0° C. to 30° C. 6. The device of claim 1 , wherein the lowest glass transition temperature of the base polymer is from 30° C. to 60° C. 7. The device of claim 1 , wherein the base polymer has an ultimate tensile strength greater than 8250 psi. 8. The device of claim 1 , wherein the base polymer is a segmented block copolymer. 9. The device of claim 1 , wherein the base polymer comprises polyurethane and/or polyurea segments and one or more polycarbonate or polyester segments. 10. The device of claim 1 , wherein the base polymer is a polyurethane copolymer chosen from a polycarbonate-urethane, polyether-urethane, and polyester-urethane. 11. The device of claim 1 , wherein the base polymer comprises a polymer selected from the group consisting of epoxies, polystyrene, polyoxymethylene, polysiloxanes, polyethers, polyacrylics, polymethacrylic, polyesters, polycarbonates, polyamide, poly(ether ketone), and poly(ether imide). 12. The device of claim 1 , wherein the diffusion-resistance layer further comprises a hydrophilic polymer. 13. The device of claim 12 , wherein the hydrophilic polymer is selected from the group consisting of polyvinyl alcohol, polyethylene glycol, polyacrylamide, polyacetate, polyethylene oxide, polyethyleneamine, polyvinylpyrrolidone, polyoxazoline, and mixtures thereof. 14. The device of claim 12 , wherein the hydrophilic polymer is blended with the base polymer. 15. The device of claim 12 , wherein the hydrophilic polymer is covalently bonded to the base polymer. 16. The device of claim 12 , wherein the base polymer or hydrophilic polymer comprises at least one crosslinker, wherein the at least one crosslinker comprises a polymer or an oligomer, the oligomer comprising polyfunctional isocyanate, polyfunctional aziridine, or polyfunctional carbodiimide. 17. The device of claim 1 , wherein the diffusion-resistance layer comprises a blend of a polycarbonate-urethane base polymer and polyvinylpyrrolidone. 18. The device of claim 1 , wherein the diffusion-resistance layer is from 0.01 μm to about 250 μm thick. 19. The device of claim 1 , wherein the sensor has a drift of less than or equal to 10% over 10 days. 20. The device of claim 1 , wherein the transcutaneous sensor comprises an electrode. 21. The device of claim 1 , wherein the device is configured for continuous measurement of an analyte concentration. 22. The device of claim 1 , wherein the analyte is glucose. 23. The device of claim 1 , wherein the base polymer has a plurality of glass transition temperatures as measured using ASTM D3418.

Assignees

Inventors

Classifications

  • Magnoliopsida (dicotyledons) · CPC title

  • Devices therefor, e.g. test element readers, circuitry (details not specific to biochemical electrodes G01N33/4875) · CPC title

  • Monitoring the patient using a local or closed circuit, e.g. in a room or building (A61B5/0017 takes precedence) · CPC title

  • using two or more compounds having active hydrogen in the first polymerisation step · CPC title

  • using enzyme electrodes, e.g. with immobilised oxidase · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11262326B2 cover?
Disclosed are devices for determining an analyte concentration (e.g., glucose). The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and a sensing membrane located over the sensor. The sensing membrane comprises a biointerface layer which interfaces with a biological fluid containing the analyte to be measured. The biointerface layer can co…
Who is the assignee on this patent?
Dexcom Inc
What technology area does this patent fall under?
Primary CPC classification G01N27/3273. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).